Adjuvant Therapy News and Research

RSS
Adjuvant Therapy is treatment given after the primary treatment to increase the chances of a cure. Adjuvant therapy may include chemotherapy, radiation therapy, hormone therapy, or biological therapy.
Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Adjuvant therapy may not improve survival for rare cancers

Adjuvant therapy may not improve survival for rare cancers

Adjuvant therapy after surgical removal of rare tumors may not provide survival benefit

Adjuvant therapy after surgical removal of rare tumors may not provide survival benefit

Researchers block common siren call of glioblastoma and metastatic breast cancer

Researchers block common siren call of glioblastoma and metastatic breast cancer

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Breast cancer adjuvant treatment discordance linked to general distrust in healthcare system

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Study describes link between key melanoma signaling pathway and novel class of drugs

Study describes link between key melanoma signaling pathway and novel class of drugs

Increased genomic risk can make small tumors aggressive, study says

Increased genomic risk can make small tumors aggressive, study says

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

Lymph node removal may not be needed for all melanoma patients, study finds

Lymph node removal may not be needed for all melanoma patients, study finds

Adherence to NCCN Guidelines spares breast cancer patients from unnecessary tests

Adherence to NCCN Guidelines spares breast cancer patients from unnecessary tests

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Adding a second HER2-targeted treatment may improve outcomes for some women with breast cancer

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

Study shows effectiveness of 3 months of chemotherapy in colon cancer patients after surgery

Targeted therapy appears to be more effective in preventing lung cancer recurrence

Targeted therapy appears to be more effective in preventing lung cancer recurrence

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy